Journal article
A Platform for Generation of Chamber-Specific Cardiac Tissues and Disease Modeling
Abstract
Tissue engineering using cardiomyocytes derived from human pluripotent stem cells holds a promise to revolutionize drug discovery, but only if limitations related to cardiac chamber specification and platform versatility can be overcome. We describe here a scalable tissue-cultivation platform that is cell source agnostic and enables drug testing under electrical pacing. The plastic platform enabled on-line noninvasive recording of passive …
Authors
Zhao Y; Rafatian N; Feric NT; Cox BJ; Aschar-Sobbi R; Wang EY; Aggarwal P; Zhang B; Conant G; Ronaldson-Bouchard K
Journal
Cell, Vol. 176, No. 4, pp. 913–927.e18
Publisher
Elsevier
Publication Date
February 2019
DOI
10.1016/j.cell.2018.11.042
ISSN
0092-8674